Sign in
WithdrawnNo phase

A Cataract Surgery Clinical Trial

Key facts

Who runs it
Alcon Research
Where
Salt Lake City, Sioux Falls, Spring, Sugar Land, and West Des Moines, United StatesSee the 5 sites
Trial code
Status
Withdrawn
Started
Feb 2026
Ended
Jun 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • UNITY Vitreoretinal Cataract System
  • CENTURION Vision System with Active Sentry
  • Anterior segment ophthalmic surgery
Record updated
12 December 2025
Why it stopped
Sponsor's business decision based on strategic shifts

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • Clinically documented diagnosis of age-related nuclear sclerotic cataract of grade 2 or greater in both eyes
  • Both eyes with similar nuclear sclerotic cataract severity and type (within 1 cataract grade)
  • Both eyes able to be implanted with same intraocular lens material
  • Both eyes able to receive the same ophthalmic viscosurgical device (OVD)
  • Other protocol-specified inclusion criteria may apply

Who cannot take part

  • Planned intraoperative glaucoma surgery or expected postoperative procedures during the study in either study eye
  • Laser-assisted cataract surgery in either study eye
  • Any ocular disease and/or condition that, in the investigator's clinical judgement, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study
  • Other protocol-specified exclusion criteria may apply

Where in United States

  • The Eye Institute of UtahSalt Lake City, United States
  • Vance Thompson VisionSioux Falls, United States
  • Whitsett Vision GroupSpring, United States
  • Berkeley Eye CenterSugar Land, United States
  • Wolfe Eye ClinicWest Des Moines, United States

About the trial

What the trial wants to find out

The purpose of the study is to compare the efficiency and safety of UNITY™ Vitreoretinal Cataract System (UNITY VCS) to CENTURION® Vision System with Active Sentry (CAS) in adult subjects with grade 2 or greater nuclear sclerotic cataracts who require phacoemulsification in both eyes. Subjects will attend a total of 8 scheduled visits for an individual duration of participation of approximately 1 month.

The 2 groups in the trial

  • UNITY Vitreoretinal Cataract System (VCS)Treatment being tested

    Anterior segment ophthalmic surgery in one eye using UNITY Vitreoretinal Cataract System (VCS)

    Treatment: UNITY Vitreoretinal Cataract System and Anterior segment ophthalmic surgery

  • CENTURION Vision System with Active Sentry (CAS)Existing treatment, for comparison

    Anterior segment ophthalmic surgery in one eye using CENTURION Vision System with Active Sentry (CAS)

    Treatment: CENTURION Vision System with Active Sentry and Anterior segment ophthalmic surgery

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Cataract Surgery: Randomized Comparative Clinical Trial
Record updated
12 December 2025